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Selective Ring-Opening of Di-Substituted Epoxides
Catalysed by Halohydrin Dehalogenases
Elia Calderini,[a] Julia Wessel,[a] Philipp Süss,[b] Patrick Schrepfer,[a] Rainer Wardenga,[b] and
Anett Schallmey*[a]
Halohydrin dehalogenases (HHDHs) are valuable biocatalysts for
the synthesis of β-substituted alcohols based on their epoxide
ring-opening activity with a number of small anionic nucleo-
philes. In an attempt to further broaden the scope of substrates
accepted by these enzymes, a panel of 22 HHDHs was
investigated in the conversion of aliphatic and aromatic
vicinally di-substituted trans-epoxides using azide as nucleo-
phile. The majority of these HHDHs was able to convert
aliphatic methyl-substituted epoxide substrates to the corre-
sponding azidoalcohols, in some cases even with absolute
regioselectivity. HheG from Ilumatobacter coccineus exhibited
also high activity towards sterically more demanding di-
substituted epoxides. This further expands the range of β-
substituted alcohols that are accessible by HHDH catalysis.
Introduction
Enzymes are attractive catalysts as they offer the possibility to
attain building blocks through highly regio-, stereo-, and
chemoselective transformations. In this sense, halohydrin
dehalogenases (HHDHs, also called haloalcohol dehalogenases
or halohydrin hydrogen-halide-lyases), initially discovered for
their ability to degrade halogenated compounds,[1] are very
useful biocatalysts that catalyse the reversible dehalogenation
of vicinal haloalcohols via formation of the corresponding
epoxides.[2,3] For a practical application of HHDHs, their promis-
cuous epoxide ring-opening activity with a range of small
anionic nucleophiles such as azide, cyanide, nitrite, cyanate or
thiocyanate is even more attractive as it enables the regio- and
stereoselective formation of novel C  N, C  C, C  O and C  S
bonds.[4,5] Hence, HHDH-catalysed reactions give access to
synthetically important ß-substituted alcohols and chiral epox-
ides. Biocatalytic examples include the synthesis of ethyl (R)-4-
cyano-3-hydroxybutyrate, a chiral synthon for the production of
statin side chains,[6] enantiopure epihalohydrins,[7,8] highly
enantioenriched oxazolidinones[9] and tertiary alcohols.[10,11]
HHDHs belong to the superfamily of short-chain dehydro-
genases/reductases (SDR). In contrast to other SDR enzymes,
their catalytic mechanism does not require any cofactor.[12] In
HHDHs, the cofactor binding pocket found in SDR enzymes is
replaced by a nucleophile binding pocket.[13] Moreover, they
feature a conserved catalytic triad composed of Ser  Tyr  Arg,
which acts in a concerted manner to catalyse the epoxide
formation and concomitant halide release.[13,14] In the epoxide
ring-opening reaction, the nucleophilic attack typically occurs at
the sterically less-hindered carbon atom following an SN2
mechanism.[15] Until recently, only terminal epoxides had been
reported to be accepted as substrates by HHDHs. When
studying HheC from Agrobacterium tumefaciens, HheA2 from
Arthrobacter sp. AD2 and HheB2 from Mycobacterium sp. GP1
for their activity on vicinally di-substituted as well as cyclic
epoxides, Majeric Elenkov et al. found that none of the tested
HHDHs exhibited activity towards these sterically more de-
manding epoxides.[16] Only in one paper by Hasnaoui-Dijoux
et al., it is briefly noted that HheC was observed to catalyse the
ring-opening of 2,3-epoxyheptane with nitrite as nucleophile
but without experimental detail.[4]
We recently reported the identification of a large set of
novel HHDH enzymes based on a database mining approach
using HHDH-specific sequence motifs.[17] Together with the five
previously known HHDHs, they compose a broad family of
HHDH enzymes subdivided into six phylogenetic subtypes A
through G. A representative subset of 17 novel HHDHs, which
span the entire phylogenetic tree, was subsequently cloned and
biocatalytically characterised.[18] This way, HheG from Ilumato-
bacter coccineus was found to convert cyclic epoxides such as
cyclohexene oxide and limonene oxide with synthetic useful
activity.[19] This represents the first example for the ring-opening
of cyclic epoxide substrates using a halohydrin dehalogenase.
Intrigued by this finding, we aimed to study also other
vicinally di-substituted but non-cyclic epoxides as substrates in
bioconversions with halohydrin dehalogenases. Employing a
representative set of 19 new and three previously known HHDH
enzymes, we screened for activity towards five different racemic
di-substituted trans-epoxides with aliphatic or aromatic sub-
stituents using azide as nucleophile (Scheme 1). The resulting
azidoalcohols are useful intermediates for the synthesis of
corresponding aliphatic and arylaliphatic aminoalcohols. This is
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the first comprehensive study of the ring-opening of vicinally
di-substituted epoxides catalysed by a large set of HHDHs.
Results and Discussion
A subset of 22 HHDHs from our panel, containing enzymes
from all six phylogenetic HHDH subtypes, was tested in
bioconversions of racemic di-substituted trans-epoxides 1–5
using azide as exemplary nucleophile (Scheme 1). As a result, 17
(including HheC) out of 22 tested HHDHs displayed activity in
the conversion of the two aliphatic substrates trans-2,3-
epoxyhexane (1) and trans-2,3-epoxyheptane (2), affording the
corresponding azidoalcohols in varying yields (Table 1). In
contrast, significantly less HHDHs converted the sterically more
demanding epoxides trans-4,5-epoxyhexan-1-ol (3), trans-3,4-
epoxyheptane (4) and trans-β-methylstyrene oxide (5). HheG
from Ilumatobacter coccineus was active on all five epoxide
substrates yielding highest conversion for substrates 1, 3, 4 and
5 among all tested HHDHs. Significant conversion of 5 by HheG
was unexpected as the enzyme was shown to exhibit only very
little activity on styrene oxide.[18] For HheA2 and HheB2, hardly
any product formation in the conversion of the tested vicinally
di-substituted epoxides was observed, which is in agreement
with previous findings.[15]
Interestingly, addition of a terminal hydroxyl group, as
present in substrate 3, abolished activity of all tested HHDHs
that displayed activity on the corresponding non-hydroxylated
epoxide 1, except for HheG. Though this hydroxyl group is at
the opposite end of the aliphatic molecule compared to the
epoxide ring, it can support unproductive binding of the
substrate in the enzyme active site (see also below). Surpris-
ingly, only HheG, but not HheG2, is able to convert epoxide 3,
albeit both enzymes share 74% sequence identity on protein
level.[19]
Comparing substrates 2 and 4, which differ in the position
of their epoxide ring, only a reduced number of HHDHs was still
active on trans-3,4-epoxyheptane (4). Enzymes HheA3, HheD,
HheD2, HheD3 and HheD5, as well as HheG2 gave low to
moderate conversions, whereas HheG converted 4 completely
within 15 h reaction time.
The vicinally di-substituted epoxide substrates 1–5 each
contain two stereocentres. Depending on the site of nucleo-
philic attack and the stereoconfiguration of the substrate during
HHDH-catalysed epoxide ring-opening, two regioisomers and
their respective pairs of enantiomers can be attained
(Scheme 2). Thus, the regioselectivity of active HHDHs in the
conversion of substrates 1–5 was studied. Most enzymes
formed both regioisomeric products a and b in varying ratios
Scheme 1. HHDH-catalysed azidolysis of racemic di-substituted trans-epox-
ides (1–5) resulting in the formation of two possible regioisomeric
azidoalcohols (6–10).
Table 1. Substrate conversions and ratio of formed regioisomeric products a:b obtained in biocatalytic reactions of substrates 1–5 with HHDHs using azide
as nucleophile. All biotransformations were performed in duplicate.
Conversion [%] (ratio of regioisomeric products a:b)
HHDH[a] 1 2 3 4 5
HheA2 3.1�0.2 (n.d.[b]) 3.1�0.2 (76 :24) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.8� <0.1 (n.d.[b])
HheA3 52� <0.1 (92 :8) 97� <0.1 (97 :3) <0.01 (n.d.[b]) 1.2�0.3 (n.d.[b]) 0.9�0.1 (n.d.[b])
HheA5 3.6� <0.1 (n.d.[b]) 6.1� <0.1 (98 :2) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.5� <0.1 (n.d.[b])
HheB2 5.4� <0.1 (n.d.[b]) 5.6� <0.1 (88 :12) n.d.[b] n.d.[b] n.d.[b]
HheB3 13�0.9 (73 :27) 13�0.7 (67 :33) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.6� <0.1 (n.d.[b])
HheB4 <0.1 (n.d.[b]) 0.2� <0.1 (n.d.[b]) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.5�0.1 (n.d.[b])
HheB5 59�1.6 (88 :12) 97�0.1 (87 :13) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.5�0.1 (n.d.[b])
HheB6 76�5.3 (90 :10) 100�0.1 (89 :11) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.5� <0.1 (n.d.[b])
HheB7 81�2.4 (90 :10) 100� <0.1 (89 :11) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.6� <0.1 (n.d.[b])
HheC 44�12.6 (97 :3) 100�0.4 (98 :2) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.6�0.3 (n.d.[b])
HheD 44�2.8 (50 :50) 94�1.3 (55 :45) <0.01 (n.d.[b]) 8.6�0.2 (55 :45) 0.5�0.2 (n.d.[b])
HheD2 64�2.2 (50 :50) 90�4.9 (50 :50) <0.01 (n.d.[b]) 2.6�0.1 (69 :31) 0.6� <0.1 (n.d.[b])
HheD3 88�3.8 (50 :50) 100� <0.1 (57 :43) <0.01 (n.d.[b]) 25�2.2 (69 :31) 1.1�0.3 (7 :93)
HheD5 100� <0.1 (64 :36) 100� <0.1 (50 :50) <0.01 (n.d.[b]) 4.5�0.6 (49 :51) 0.7� <0.1 (n.d.[b])
HheE 100� <0.1 (98 :2) 100� <0.1 (99 :1) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.4�0.2 (n.d.[b])
HheE2 12� <0.1 (91 :9) 85� <0.1 (98 :2) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.7�0.1 (n.d.[b])
HheE3 16� <0.1 (89 :11) 92� <0.1 (99 :1) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.5�0.1 (n.d.[b])
HheE4 <0.1 (n.d.[b]) 15� <0.1 (97 :3) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.6� <0.1 (n.d.[b])
HheE5 86� <0.1 (98 :2) 100� <0.1 (99 :1) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.7� <0.1 (n.d.[b])
HheF 56�0.7 (86 :14) 70�2.1 (83 :17) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 1.3�0.2 (13 :87)
HheG 100� <0.1 (50 :50) 100�0.1 (60 :40) 49�9.3 (92 :8) 99�0.1 (51 :49) 44�1.9 (0.4 : 99.6)
HheG2 26�2 (50 :50) 96�0.9 (50 :50) <0.01 (n.d.[b]) 17�4.4 (76 :24) 24�2.1 (0.4 : 99.6)
Control 1.6�0.5 (50 :50) 1.6�0.6 (50 :50) <0.01 (n.d.[b]) <0.01 (n.d.[b]) 0.8�0.1 (1 :99)
[a] Original strains and accession numbers of all enzymes are listed in Table S1 in the supporting information. [b] not determined
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(Table 1). HheA3, HheC and all tested E-type enzymes exhibited
high regioselectivity for substrates 1 and 2, giving 2-azidohex-
an-3-ol (6a) and 2-azidoheptan-3-ol (7a) almost exclusively. In
contrast, enzymes from the HHDH subfamily D as well as HheG
and HheG2 formed both regioisomers (6a and 6b, as well as 7a
and 7b) in roughly equal amounts. The same was observed for
chemical background azidolysis of 1 and 2 (“Control” in
Table 1).
Compared to the conversion of 1, the terminal hydroxyl
group present in 3 had a positive effect on HheG’s regioselec-
tivity. The enzyme produced 5-azidohexane-1,4-diol (8a) with
high preference (Table 1). None of the active enzymes seemed
to display high regioselectivity in the conversion of 4 as in all
cases both azidoalcohol regioisomers 9a and 9b were formed.
This might not be surprising considering that both substituents
of the epoxide ring are rather similar in size, differing only in
one CH2 group.
In accordance with literature,[13,15] none of the tested
enzymes exhibited a preference for formation of regioisomer b,
except in the conversion of epoxide 5. Here, HheG and HheG2
gave azidoalcohol 10b almost exclusively, whereas HheD3 and
HheF formed also small amounts of regioisomer 10a. Chemical
azidolysis of epoxide 5 afforded 10b almost exclusively as well.
In this specific case, nucleophilic attack on the benzylic carbon
is favoured due to the electronic resonance effect of the
aromatic substituent.
Furthermore, the enantioselectivity of all active enzymes in
the ring-opening of racemic epoxides 1 and 2 was analysed. For
this, product enantiomeric excesses (eeP) and corresponding
apparent E-values for each of the two possible product
regioisomers were determined. As a result, most azidoalcohols
were formed with low to moderate enantioselectivity (Table 2).
Several HHDHs, however, displayed good enantioselectivity (E>
15) in the formation of azidoalcohol regioisomers 6b and 7b.
Hence, nucleophilic attack on the unfavoured carbon atom
occurred with higher enantioselectivity. Interestingly, most
azidoalcohol products in the conversion of 1 and 2 were
preferentially formed in 2S,3R-configuration. This indicates that
epoxides 1 and 2 with R,R-configuration were preferentially
attacked at the sterically less hindered carbon atom (C2),
whereas regioisomers 6b and 7b were preferentially formed by
nucleophilic attack of (S,S)-1 and (S,S)-2 at the sterically more
hindered carbon atom (C3). In contrast, nucleophilic attack of
azide at C2 in (S,S)-1 and (S,S)-2 yields azidoalcohols 6a and 7a
in 2R,3S-configuration, as found for HheA3, HheE2, HheF and
HheG2 with epoxide 1 and HheE4 and HheF with epoxide 2
(Table 2). A detailed analysis of the enzymes’ regiopreferences
in the azidolysis of R,R- and S,S-enantiomers of epoxides 1 and
2 is given in Table S3 in the supporting information. Interest-
ingly, D-type HHDHs displayed a slightly higher preference for
Scheme 2. Possible regio- and stereoisomers in the azidolysis of vicinally di-
substituted trans-epoxides 1–5. The site of attack (α: less sterically hindered,
shown in blue; β: sterically more hindered, shown in plum) defines the
regioisomers obtained, while the enantioselectivity of the enzyme and the
SN2-type mechanism define the absolute configuration found in each set of
regioisomers. Hence, a total of two regioisomers a and b, each with their
respective (R,S)- and (S,R)-enantiomers, can be obtained.
Table 2. Conversions (C), enantiomeric excesses (eeP) and calculated apparent enantiomeric ratios (E
app) of regioisomeric azidoalcohols 6a,b and 7a,b
formed in the HHDH-catalysed azidolysis of epoxides 1 and 2. The absolute configuration of the preferentially formed enantiomer of each regioisomer is
given in parentheses.
6a 6b 7a 7b
HHDH[a] C [%] eeP [%] E
app C [%] eeP [%] E
app C [%] eeP [%] E
app C [%] eeP [%] E
app
HheA3 48 47 4.2 (R,S) 4.1 46 2.8 (S,R) 93 0.7 1.0 (S,R) 3.4 25.5 1.7 (S,R)
HheB3 9.7 35 2.2 (S,R) 3.6 66 5.0 (S,R) 8.7 30 1.9 (S,R) 4.3 77 7.7 (S,R)
HheB5 52 25 2.1 (S,R) 7.1 86 14 (S,R) 85 24 1.6 (S,R) 13 95 39 (S,R)
HheB6 69 24 2.6 (S,R) 7.6 89 18 (S,R) 88 16 1.4 (S,R) 11 93 28 (S,R)
HheB7 73 24 2.9 (S,R) 8.1 93 30 (S,R) 89 17 1.4 (S,R) 11 94 32 (S,R)
HheC 43 34 2.6 (S,R) 1.3 n.d.[b] n.d.[b] 97 4.6 1.1 (S,R) 2.3 90 19 (S,R)
HheD 22 28 1.9 (S,R) 22 86 17 (S,R) 51 60 4.0 (S,R) 43 87 14 (S,R)
HheD2 32 22 1.7 (S,R) 32 84 17 (S,R) 45 57 3.7 (S,R) 45 78 8.1 (S,R)
HheD3 44 65 7.7 (S,R) 44 43 3.4 (S,R) 56 76 7.4 (S,R) 43 80 9.0 (S,R)
HheD5 64 46 6.5 (S,R) 36 44 3.2 (S,R) 50 13 1.3 (S,R) 50 11 1.2 (S,R)
HheE 98 4.9 1.1 (S,R) 1.7 n.d.[b] n.d.[b] 99 3.5 1.1 (S,R) 0.8 n.d.[b] n.d.[b]
HheE2 10 71 6.4 (R,S) 1.1 n.d.[b] n.d.[b] 83 11 1.2 (S,R) 1.5 n.d.[b] n.d.[b]
HheE3 14 4.5 1.1 (R,S) 1.8 n.d. [b] n.d.[b] 90 2.3 1.0 (S,R) 1.4 n.d.[b] n.d.[b]
HheE4 <0.1 n.d.[b] n.d.[b] n.d.[b] n.d.[b] n.d.[b] 14 33 2.0 (R,S) 0.5 n.d.[b] n.d.[b]
HheE5 84 13 2.2 (S,R) 1.8 n.d.[b] n.d.[b] 99 3.5 1.1 (S,R) 0.6 n.d.[b] n.d.[b]
HheF 48 54 5.4 (R,S) 8.0 32 2.0 (S,R) 58 32 1.9 (R,S) 12 19 1.5 (S,R)
HheG 50 16 1.6 (S,R) 50 15 1.5 (S,R) 60 63 4.4 (S,R) 40 89 17 (S,R)
HheG2 13 54 3.6 (R,S) 13 67 5.6 (S,R) 48 7.4 1.2 (S,R) 48 10 1.2 (S,R)
[a] Original strains and accession numbers of all enzymes are listed in Table S1 in the supporting information. [b] not determined
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nucleophilic attack of (S,S)-1 and (S,S)-2 at the sterically more
hindered carbon atom, whereas most other HHDHs exhibited a
clear preference for nucleophilic attack of the sterically less
hindered carbon atom independent of the substrate’s stereo-
configuration. Additionally, the enantioselectivity of active
HHDHs in the ring-opening of rac-5 was determined and results
are given in Table S2 in the supporting information. No
enantioselectivity was observed in the chemical epoxide ring
opening of 1, 2 and 5 on preparative scale with azide as
nucleophile (data not shown).
Among the tested halohydrin dehalogenases, HheG was the
only enzyme able to convert all five epoxide substrates. This
might be explained by the broad and open active site which is
present in HheG’s crystal structure.[19] In contrast, other HHDHs
with solved crystal structure, namely HheA/A2, HheB/B2 and
HheC,[13,20,21] possess active sites that are more buried within the
protein structure, with a rather narrow substrate channel
leading to the active site. Hence, the broad active site cleft of
HheG likely offers more space for the binding of bulky
substrates such as the herein tested vicinally di-substituted
epoxides. This is also supported by calculations of the active
site volume of HheG, which was found to be 2.7 times larger
than the calculated active site volume of HheC.[19] On the other
hand, epoxide substrates with much bulkier substituents on
both carbon atoms of the epoxide ring are likely not accepted
by HheG as it was previously shown that trans-stilbene oxide
was not converted by HheG or other tested HHDHs.[18]
HheC from A. tumefaciens was previously demonstrated to
be R-selective, especially in the conversion of terminal aromatic
epoxides. This enantioselectivity is caused by non-productive
binding of the respective (S)-epoxides in the active site of
HheC.[15] Here, this HHDH seems significantly less stereoselective
in the conversion of 1 and 2 as products 6a and 7a have been
obtained with rather low ee (34% and 5%, respectively). On the
other hand, HheC displayed very high regioselectivity yielding
azidoalcohol regioisomers 6a and 7a almost exclusively. The
regioselectivity of a HHDH during epoxide ring opening of
vicinally di-substituted epoxides is determined by the exact
positioning of epoxide substrate and nucleophile in the active
site of the enzyme. This relative positioning of epoxide ring and
nucleophile to each other will dictate which of the two carbon
atoms of the epoxide ring can be attacked by the nucleophile.
To investigate this in more detail for HheC, molecular docking
of both enantiomers of epoxides 1–5 into the enzyme’s active
site was performed. This revealed that both substrate enantiom-
ers of 1 and 2 bind in similar productive orientations with the
methyl-substituted carbon atom in closer proximity to the
nucleophile binding pocket (Figure 1A and B). This is in line
with our experimental data that both epoxide enantiomers can
be converted by HheC, but the methyl-substituted carbon atom
is always attacked preferentially, resulting in the observed high
regio- but low enantioselectivity of this enzyme. In contrast,
docking of (R,R)- and (S,S)-4 yielded possible binding modes
with the epoxide oxygen being too far away from the serine of
the catalytic triad to facilitate catalysis (Figure 1D).
Similarly, for both enantiomers of epoxide 5 no binding
mode with the epoxide oxygen in hydrogen bonding distance
to the catalytic triad serine and tyrosine of HheC was observed
Figure 1. Docking results for HheC (PDB: 1ZMT) with substrates 1 (A), 2 (B), 3 (C), 4 (D) and 5 (E). Substrates with R,R-configuration are shown in light blue,
while substrates with S,S-configuration are shown in orange. Hydrogen bonds between epoxide oxygen and catalytic residues S132 and Y145 are represented
as green dotted lines. The water molecule present in the nucleophile binding pocket is shown as green sphere to indicate the position of the nucleophile.
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(Figure 1E). This is again in agreement with our experimental
data obtained for HheC, which did not convert epoxides 4 and
5. Docking of epoxide 3 revealed non-productive binding
modes for both substrate enantiomers with the terminal
hydroxyl group pointing towards the catalytic amino acid
residues (Figure 1C). This flipped binding mode of 3 found for
HheC might also occur in other HHDHs and could thus explain
the lack of activity of most HHDHs toward this epoxide. Since
possible unproductive binding modes could be obtained for 3,
4 and 5, all three epoxides might act as inhibitors of HheC.
For comparison, similar dockings of epoxides 1–5 were also
performed with HheG. Here, possible productive binding modes
of both enantiomers of 1 and 2 were obtained with the epoxide
oxygen in hydrogen bonding distance to the catalytic serine
and tyrosine (Figure 2). In contrast to HheC, however, both
substrate enantiomers display different orientations with the
longer alkyl side chain pointing in opposite directions. This is
only possible due to the much larger active site cavity of HheG
compared to HheC. With the other three substrates (3–5) and
HheG, the docking results are less informative as not all
substrate enantiomers yielded possible productive binding
modes (Supporting Information, S4). This is not surprising
considering that no substrate-bound structure of HheG is
available yet. Hence, the resulting substrate binding poses
found for HheG may not reflect the real binding modes. In case
of HheC, molecular dockings were performed using an epoxide-
bound enzyme structure (PDB: 1ZMT).[15] Therefore, the ob-
tained docking results will be more reliable. As no crystal
structure of a member of HHDH subfamily E has been
determined so far, no structural insights into the observed high
regioselectivity could be gained for these enzymes.
Selected regioselective HHDH-catalysed reactions were also
performed on preparative scale to demonstrate the synthetic
potential of this class of enzymes. For this, epoxide substrates 1
and 2 were each converted with a regioselective HHDH (HheE
for substrate 1 and HheE5 for substrate 2) by means of whole-
cell biocatalysis. Using each 200 mg (50 mM) of epoxide per
reaction, 142 mg of regioisomer 6a and 151 mg of regioisomer
7a (50% and 48% isolated yield, respectively) were obtained in
pure form.
Conclusions
A set of 22 halohydrin dehalogenases, representing all currently
known phylogenetic subtypes, was studied in the azidolysis of
five vicinally di-substituted epoxides. The majority of these
enzymes displayed significant activity towards simple aliphatic
epoxides that carried a methyl group at one of the carbon
atoms of the epoxide ring. Several HHDHs were even found to
be highly regioselective, facilitating the synthesis of regioiso-
merically pure azidoalcohols on preparative scale. HheG from
Ilumatobacter coccineus converted also sterically more demand-
ing non-terminal epoxides with good to high activity. Overall,
the observed regio- and stereoselectivity of active enzymes
towards the tested vicinally di-substituted epoxides was found
to be enzyme- and substrate-dependent. Docking studies based
on an epoxide-bound structure of HheC revealed first structural
insights into the observed substrate and regio-selectivity of this
enzyme.
With this, we could demonstrate that the substrate scope of
HHDHs is not limited to terminal epoxides. Instead, they can be
applied in the conversion of non-terminal epoxide substrates,
thus, expanding the range of accessible β-substituted alcohols.
This further broadens the biocatalytic applicability of HHDHs, in
particular of HheG, substantially. Further improvement of the
enzymes’ enantioselectivities by protein engineering will enable
the synthesis of optically pure products in the future.
Experimental Section
Chemicals
Trans-2-hexene was purchased from Acros Organics (Geel, Belgium),
trans-2-heptene was purchased from abcr GmbH (Karlsruhe,
Germany). Trans-β-methylstyrene and trans-3-heptene were pur-
chased from TCI Deutschland GmbH (Eschborn, Germany). Trans-2-
hexen-1-ol was purchased from J&K Scientific (Lommel, Belgium).
(1S,2S)-(  )-1-phenylpropylene oxide and (1R,2R)-(+)-1-phenylpropy-
lene oxide were purchased from Sigma-Aldrich (Darmstadt, Ger-
many).
Figure 2. Docking results for HheG (PDB: 5O30) with substrates 1 (A) and 2 (B). Substrates with R,R-configuration are shown in light blue, while substrates with
S,S-configuration are shown in orange. Hydrogen bonds between epoxide oxygen and catalytic residues S152 and Y165 are represented as green dotted lines.
The water molecule present in the nucleophile binding pocket is shown as green sphere to indicate the position of the nucleophile.
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Racemic epoxides trans-2,3-epoxyhexane (1) and trans-2,3-epoxy-
heptane (2) were synthesised according to Sharma et al. using a
slightly modified protocol.[22] Epoxidations were carried out in
CH2Cl2 (40 mLg
  1 of alkene). m-Chloroperbenzoic acid (1.5 eq.) was
added in small portions over 15 min at room temperature (RT).
After 1 h at RT, the mixture was stirred on ice for 5 min and the
white slurry was filtered. 5%w/v aq. Na2SO3 (40 mLg
  1 alkene) was
added and stirred at RT for 15 min, then the phases were separated.
The aqueous layer was extracted two times with CH2Cl2. The
combined organic layers were washed with sat. aq. NaHCO3 (1×)
and brine (1×), dried over MgSO4 and filtered before solvent
removal by evaporation. The epoxides were purified by column
chromatography using a mixture of cyclohexane/ethyl acetate,
95 :5.
Racemic trans-4,5-epoxyhexan-1-ol (3), trans-3,4-epoxyheptane (4)
and trans-β-methylstyrene oxide (5) were synthesised by mixing
the respective alkene to a final concentration of 200 mM in water
with 30% acetonitrile and 10% of acetone. 3 eq. of oxone® were
added portion-wise over 4 hours. The pH was kept at 8 by adding
NaHCO3 to the solution.
[23] The reactions were followed by TLC.
When all substrate was converted, the reaction mixture was
extracted three times with tert-butylmethyl ether (TBME). The
combined organic layers were washed with brine (1×), dried over
Na2SO4 and filtered before solvent removal by evaporation. The
epoxides were purified by column chromatography with
cyclohexane/isopropanol (95 :5) for 3, cyclohexane/ethyl acetate
(95 :5) for 4 and cyclohexane/ethyl acetate (90 :10) for 5. Formation
and purity of the epoxides was confirmed by NMR and resulting
NMR data were consistent with literature data.[24–26]
Bacterial Strains and Plasmids
The strains Escherichia coli BL21(DE3) (Life Technologies, Darmstadt,
Germany), E. coli C43(DE3) (Lucigen Corporation, Middleton, WI,
USA) and E. coli Top10 (Life Technologies) were used as hosts for
heterologous protein production. All HHDH genes except hheA2,
hheB2 and hheC were expressed from pET28a(+)-based vectors,
utilizing a T7 promotor and resulting in a N-terminal hexahistidin
(His6) tag fusion.[17] Instead, vectors pBAD-hheA2, pBAD-hheB2 and
pBAD-hheC, utilizing an arabinose-inducible promotor, were used
for the expression of the HheA2, HheB2 and HheC genes,
respectively, as described previously.[12,27]
Expression and Purification of HHDHs
All HHDH enzymes except HheE4 and HheG2 were produced and
purified as reported previously.[12,18] Enzymes HheE4 and HheG2
were produced in E. coli BL21(DE3). Respective overnight cultures
were used to inoculate (10%v/v) 500 mL TB medium (4 mLL  1
glycerol, 12 gL  1 peptone, 24 gL  1 yeast extract, 0.17 M KH2PO4,
0.74 M K2HPO4) supplemented with 50 mgL
  1 kanamycin and
0.2 mM IPTG. Expression cultures were grown at 22 °C for 24 h. Cells
were harvested by centrifugation (4,400 g, 20 min at 4 °C) and cell
pellets were stored at   20 °C until further use. Both enzymes were
purified via affinity chromatography according to a previously
published protocol.[18] A list of all HHDHs used in this work with
their respective source organisms and accession numbers is given
in Table S2 in the supporting information.
General Biotransformation Experiment
Small-scale biotransformations (1 mL) were performed in 50 mM
potassium phosphate buffer at pH 7.5 containing 150 μgmL  1
HHDH enzyme, 5 mM substrate (1–5) and 20 mM sodium azide
(NaN3) at 25 °C. After 15 h (substrates 1–4) or 4 h (substrate 5) of
reaction, an aliquot of 400 μL was taken and extracted with the
same volume of TBME containing 0.1%v/v dodecane as internal
standard. The resulting organic phase was dried over anhydrous
MgSO4 prior to injection on GC or GC-MS. All biotransformations
were carried out in duplicate. Chemical background azidolysis was
monitored in reactions using the same reaction conditions but
omitting HHDH enzyme.
Determination of Enantiomeric Excesses
In order to distinguish trans-(2S,3S)-epoxyhexane and trans-(2R,3R)-
epoxyhexane as well as trans-(2S,3S)-epoxyheptane and trans-
(2R,3R)-epoxyheptane on chiral GC, trans-(2S,3S)-epoxyhexane (S,S-
1) and trans-(2S,3S)-epoxyheptane (S,S-2) were selectively synthes-
ised according to a published protocol using E. coli whole cells
harbouring the styrene monooxygenase (StyAB) from Rhodococcus
sp. ST-10.[28,29] Assignment of all azidoalcohol enantiomers on chiral
GC was achieved by further conversion of the obtained (S,S)-1 and
(S,S)-2 using each a regioselective and a non-regioselective HHDH.
Using a regioselective HHDH (HheE5 for 2 and HheE for 1), only
(2R,3S)-6a and (2R,3S)-7a are produced, while using non-regiose-
lective enzymes (HheD5 for 2 and HheG for 1), (2R,3S)-6a, (2S,3R)-
6b, (2R,3S)-7a and (2S,3R)-7b are obtained. Reactions were
performed in 50 mM potassium phosphate buffer at pH 7.5 using
5 mM (S,S)-1 or (S,S)-2, 150 μgmL  1 HHDH and 20 mM sodium azide
at 25 °C. After 15 h, an aliquot of 400 μL was taken and extracted
with the same volume of TBME containing 0.1%v/v dodecane as
internal standard. The resulting organic phase was dried over
anhydrous MgSO4 before injection on chiral GC. GC-MS analysis of
the same material was performed to assign the different regioisom-
ers of 6 and 7.
The assignment of enantiomers of azidoalcohols 10a and 10b on
chiral GC was performed in a similar way starting from commer-
cially available enantiopure epoxides (S,S)-5 and (R,R)-5. Due to the
SN2-type mechanism and the observed regioselectivity of the
chemical azidolysis of 5, chemical conversion of (S,S)-5 lead to an
excess of (1R,2S)-1-azido-1-phenylpropan-2-ol (10b) next to a small
amount of (1S,2R)-2-azido-1-phenylpropan-1-ol (10a). In contrast,
ring-opening of the opposite enantiomer (R,R)-5 generated (1S,2R)-
1-azido-1-phenylpropan-2-ol (10b) in excess and a small amount of
(1R,2S)-2-azido-1-phenylpropan-1-ol (10a).
Preparative Scale Biotransformation
Preparative-scale conversions of 1 and 2 were performed using
whole cells of E. coli harbouring either HheE, or HheE5. All
biotransformations were performed in 40 mL of 50 mM potassium
phosphate buffer at pH 7.5 containing a cell density of OD600=40
(equivalent to 60 g wet cells per litre reaction), 50 mM of either 1 or
2 and 100 mM sodium azide (NaN3). After 24 h at 25 °C, the reaction
mixture was extracted with 40 mL TBME and filtered through
Celite®. The extracted organic layer was washed with brine (1×) and
MilliQ water (1×), dried over Na2SO4 and filtered before solvent
evaporation. 142 mg (50% yield) of 6a and 151 mg (48% yield) of
6b could be recovered after column chromatography using
cyclohexane/diethyl ether, 90 :10.
Chemical Synthesis of Authentic Azidoalcohol Standards
1 mmol of either trans-2,3-epoxyhexane (100 mg) or trans-2,3-
epoxyheptane (114 mg) were mixed with 202 mg of NaN3 (3.1 eq.)
and 166 mg of NH4Cl (3.1 eq.) in 3.5 mL methanol and refluxed at
65 °C until no more substrate was visible on TLC (5–6 h). The
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reaction mixture was then diluted with diethyl ether, washed with
brine, the water phase was then extracted twice with diethyl ether.
The organic layers were combined and dried over Na2SO4. The
crude extracts were purified by column chromatography
(cyclohexane/diethyl ether, 90 :10) yielding 52% azidohexanol (6)
and 48% azidoheptanol (7).[30]
Following a similar protocol, azidoalcohols 8, 9 and 10 were
synthesised by dissolving the corresponding epoxides 3–5 in MeOH
with 5% H2O to a final concentration of 200 mM, NaN3 (3.1 eq.) and
NH4Cl (3.1 eq.) were added and the reaction was stirred over night
at 65 °C under reflux. Methanol was evaporated, the crude extract
was dissolved in TBME and washed with the same volume of brine
(1×). The water phase was extracted three times with TBME. The
combined organic layers were dried over Na2SO4 and filtered before
solvent removal by evaporation. Diastereomeric mixtures of 8a/b,
9a/b and 10a/b were purified by column chromatography using
chloroform/acetone, 95 :5; cyclohexane/ethyl acetate, 95 :5, and
heptane/ethyl acetate, 70 :30, respectively.
Diastereomeric mixture of 2-azidohexan-3-ol (6a) and 3-azido-
hexan-2-ol (6b): pale oil, 1H NMR (600 MHz, CDCl3) δ=3.90–3.81
(m, 1H, 6b), 3.65–3.58 (m, 1H, 6a), 3.52 (dq, J=6.7, 3.9, 1H, 6a),
3.42–3.35 (m, 1H, 66b), 1.61–1.29 (m, 14H, 6a and 6b), 1.25 (d, J=
6.7, 3H, 6a), 1.19 (d, J=6.4, 3H, 6b), 0.96 (t, J=7.2, 3H, 6b), 0.94 (t,
J=7.3, 3H, 6a). 13C NMR (151 MHz, CDCl3) δ 73.55 (6a), 69.99 (6b),
67.92 (6b), 61.77 (6a), 34.57 (6a), 32.07 (6b), 19.65 (6b), 18.96 (6a),
18.13 (6b), 13.91 (6a), 13.80 (6b), 13.11 (6a). ESI-HRMS: [M+Na+]=
166.09524 m/z (calculated [M+Na+]=166.09508 m/z).
Diastereomeric mixture of 2-azidohexan-3,6-diol (8a) and 3-
azidohexan-2,6-diol (8b): pale oil, 1H NMR (600 MHz, CDCl3) δ=
3.92–3.85 (m, 2H, 8b), 3.82–3.60 (m, 8a 3H, 8b 1H), 3.50–3.44 (m,
1H, 8a), 3.42–3.40 (m, J=4.98, 1H, 8b), 2.86 (s, 1H, 8a), 2.63 (s, 1H,
8b), 2.34 (s, 1H, 8a), 2.17 (s, 1H, 8b), 1.65–1.34 (m, 8H, 8a and 8b),
0.97 (t, J=7.0, 3H, 8a), 0.96 (t, J=6.9, 3H, 8b). 13C NMR (151 MHz,
CDCl3) δ 73.80 (8a), 72.39 (8b), 67.04 (8b), 64.64 (8a), 63.33 (8a),
62.60 (8b), 36.00 (8b), 32.83 (8a), 19.74 (8a), 19.01 (8b), 14.13 (8b),
14.03 (8a). ESI-HRMS: [M+Na+]=182.09010 m/z (calculated [M+
Na+]=182.0905 m/z).
Diastereomeric mixture of 3-azidoheptan-4-ol (9a) and 4-azido-
heptan-3-ol (9b): pale oil, 1H NMR (600 MHz, CDCl3) δ 3.72–3.64 (m,
1H, 9a), 3.62–3.55 (m, 1H, 9b), 3.42–3.32 (m, 1H, 9b), 3.31–3.23 (m,
1H, 9a), 1.73–1.31 (m, 14H, 9a and 9b), 1.04 (t, J=7.4 Hz, 3H, 9a),
1.00 (t, J=7.4 Hz, 3H, 9b), 0.96 (t, J=7.1 Hz, 3H, 9b), 0.95 (t, J=
7.2 Hz, 3H, 9a). 13C NMR (151 MHz, CDCl3) δ=75.64 (9b), 73.64 (9a),
69.46 (9a), 67.26 (9b), 34.70 (9a), 31.74 (9b), 25.58 (9b), 22.90 (9a),
19.93 (9b), 19.20 (9a), 14.20 (9a), 14.10 (9b), 11.24 (9a), 10.43 (9b).
ESI-HRMS: [M+Na+]=180.11081 m/z (calculated [M+Na+]=
180.1112 m/z).
Obtained NMR data for 7a/b[30] and 10a/b[31,32] were consistent with
literature data.
Analytical Methods
Achiral GC analysis was performed on a GC-2010 plus gas
chromatograph (Shimadzu, Duisburg, Germany) equipped with an
Optima 5 ms column (Macherey-Nagel, Düren, Germany) and FID
detection using hydrogen as carrier gas. Chiral GC analysis was
performed on a GC-2010 plus gas chromatograph (Shimadzu)
equipped with two different chiral columns and FID detection using
hydrogen as carrier gas. A Lipodex E column (Macherey-Nagel) was
used for the separation of azidoalcohol products 6–10, whereas a
HYDRODEX γ-DiMOM column (Macherey-Nagel) was used for the
separation of epoxide substrates 1–5. Temperature programs and
retention times are listed in Table S23 in the supporting informa-
tion.
Conversions of epoxides into the corresponding azidoalcohols were
determined by achiral GC based on relative peak areas. Ratios of
regioisomers 6a/b, 8a/b and 9a/b were calculated based on peak
areas derived from chiral GC, whereas ratios of regioisomers 7a/b,
10a/b, were calculated based on peak areas derived from achiral
GC. Enantiomeric excesses (ee) of azidoalcohol products 6, 7 and
10 were calculated according to Chen et al. based on chiral GC
data.[33] Apparent enantiomeric ratios (Eapp) of HHDHs for the
formation of regioisomeric products 6a and 6b, 7a and 7b as well
as 10a and 10b were calculated according to Chen et al. based on
conversion (C) and product enantiomeric excess (eeP).
[33]
GC-MS analysis of azidoalcohol products was performed on a
Shimadzu GCMS-QP2010SE equipped with a ZB-5MS GUARDIAN
column (Phenomenex) and helium as carrier gas.
NMR spectra were recorded on a Bruker Avance 600 MHz
spectrometer equipped with an inverse 1H/13C/15N/31P quadruple
resonance cryoprobe head and z field gradients. The sample was
dissolved in deuterated chloroform (CDCl3) and 1D proton, DEPT,
COSY double quantum filter, and HSQC experiments were
performed at 25 °C. The regioisomers of chemically synthesised
azidoalcohols 6, 8 and 9 were identified by NMR spectroscopy
employing COSY and HSQC techniques and further compared to
the assignment of regioisomers by GC and GC-MS.
Docking Studies
Molecular docking of MM2-force field energy minimized (S,S)- and
(R,R)-1 to 5 into the active site of a monomeric representation of
HheC (PDB-ID: 1ZMT) and HheG (PDB-ID: 5O30) was performed
using the AutoDockVina program environment of YASARA
Structure.[34,35] All ten substrate structures were docked into a
simulation cell (X size=25 Å, Y size=25 Å, Z size=25 Å; angles: α=
90°, β=90°, γ=90°) around the four residues K91, L155, E197 and
E216 for HheC and the corresponding residues D111, I175, E214
and E233 in HheG. For each substrate, 999 docking runs were
performed with atoms and bonds of the corresponding substrates
set as rigid. The only exception is substrate 3 with HheG where a
flexible ligand was necessary to obtain one cluster with productive
binding. Docking of each substrate resulted in one or more clusters
of similar binding modes which were energy minimized using the
YASARA2-force field after inserting the water molecule of the
nucleophile binding pocket as fixed element. This water molecule is
present in the respective crystal structures and represents the
position of the nucleophile in the binding pocket. Figures of the
structures with docked ligands were generated with PyMOL
Molecular Graphics System version 2.2.3 (Schrödinger, LLC, New
York, NY, USA).
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